Research letterThe effect of biologic therapy for immune-mediated inflammatory diseases on clinical outcomes of COVID-19 in the greater Houston area: A retrospective chart review
Cited by (0)
Funding sources: None.
IRB approval status: Approved by the IRBs of MD Anderson and the University of Texas Health Science Center at Houston.
Key words: biologics; COVID-19; cytokines; dermatology; immunosuppression; interleukins.
Reprints not available from the authors.
© 2022 by the American Academy of Dermatology, Inc.